ITM and CNL sign Memorandum of Understanding to pursue global development, production of rare medical radioisotope, Actinium-225

Press releases may be edited for formatting or style | October 18, 2021 Molecular Imaging

About CNL
Canadian Nuclear Laboratories is a world leader in nuclear science and technology offering unique capabilities and solutions across a wide range of industries. Actively involved with industry-driven research and development in nuclear, transportation, clean technology, energy, defence, security and life sciences, we provide solutions to keep these sectors competitive internationally.

Your Centrifuge Specialty Store

Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576

With ongoing investments in new facilities and a focused mandate, Canadian Nuclear Laboratories is well positioned for the future. A new performance standard reinforced with a strong safety culture underscores every activity.

Back to HCB News



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!

Molecular Imaging Homepage

NorthStar Medical Radioisotopes, LLC enters clinical supply agreement to support Clarity Cu-67 SAR-bisPSMA trials

SHINE Technologies, LLC announces submission of FDA Drug Master File for non-carrier-added lutetium-177

PanTera signs a second agreement for the supply of actinium-225

Radioguided surgery accurately detects and removes metastatic lymph nodes in newly diagnosed prostate cancer patients

Virtua Health installs innovative GE HealthCare systems to advance cardiac imaging in southern New Jersey

UT Health Science Center researchers awarded $20 million to develop new radiopharmaceutical cancer therapies

Lumicell announces data showing LUMISIGHT’s ability to detect tumors metastasized to multiple organs in the peritoneum

Fusion Pharmaceuticals enters license agreement with Heidelberg U, Euratom for actinium-based PSMA targeted radiotherapy

PanTera signs agreement with Bayer for the supply of actinium-225

Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

Over 900 Cleansweep Auctions End Tomorrow 05/02 - Bid Now
Over 800 Total Lots Up For Auction at Four Locations - TX 05/03, TX 05/06, NJ 05/08, WA 05/09